Substantial insider ownership aligns insiders and common shareholders. Yet, recent insider selling without corresponding buying, along with non-high insider ownership, raises concerns about company's prospects, resulting in a cautious outlook.
Hudson Technologies banks on Houghton's deep industry experience and relationship-building skills for valuable insights as it aims to expand its offerings and reinforce leadership position.
$Bumble(BMBL.US)$Bumble shares are trading higher after the company reported a 29% increase in Bumble App paying users and App revenue increased 42.2% year over year. Looking for another run. $KALA BIO(KALA.US)$shares are trading higher after the company announced UnitedHealthcare has added EYSUVIS as a covered brand on its commercial formularies and Cigna Medicare has added EYSUVIS as a preferred brand. $哈德森科技(HDSN.US)$Hudson Technologies shares are trading higher a...
哈德森科技股票讨论区
2022前三季度营收增加79%,营业利润则增长了2.8倍达到1.2亿,净利润增长2.8倍到1亿。
从毛利率可以看出近期毛利率从负4.4%提升到了37%,2022前3季度进一步提升到50%以上。
利润表显示2021年利息费用占营业利润的27%,2022前3季度利息费用占营业利润的10%,改进不是利息变少了,而是利润变高了。
5年来资产负债率从61.6%提升到74.9%后下降到67.1%,2022Q3下降到40.5%。
2021年存货从4,446万增加到9,414.4万,增加了4968.4万,远超当年净利润3225.9万,占营收的50%,不是个好现象。2022Q3存货进一步提升到了1.2亿,增加了近6千万,而前3季度的营收仅有8,950.2万。
5年来累计经营净额也远低于投资净额,而且近3年不断下降。
目前市盈率15.7,市盈率T...
• $APi Group(APG.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $23
• $Axos Financial(AX.US)$ : KBW Upgrades to Outperform from Marketperform - PT $56 (from $52)
• $美国银行(BAC.US)$: Societe Generale Upgrades to Buy from Hold - PT $37.50 (from $40.50)
• $Element Solutions(ESI.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $22 (from $24)
• $Fate Therapeutics(FATE.US)$ : BMO Capital Upgrades...
业绩很好的公司,大盘回调只有业绩好的公司是最硬的,夏季来临,做为空调制冷公司业务会进入旺季,预计全年业绩会更好。
$KALA BIO(KALA.US)$ shares are trading higher after the company announced UnitedHealthcare has added EYSUVIS as a covered brand on its commercial formularies and Cigna Medicare has added EYSUVIS as a preferred brand.
$哈德森科技(HDSN.US)$ Hudson Technologies shares are trading higher a...
Positions Details
加载中...
暂无评论